# data[].attributes.body
The implemented breast should be investigated more by the regulators due to the fact that its usage requires trained professionals to avoid possible human error during surgery, and also, may encounter issues for long term duration inside the body.

# data[].attributes.body
Cellis will be risky  since it is customized. It is hard to ensure all matrix of cellis apply to all patients.

# data[].attributes.body
CELLIS poses a higher risk because the duration of CELLIS is longer, the intended use is more specific this require training to use and it has to hold and support more cells, which is larger in size and may cause other side effects.

# data[].attributes.body
cellis  since it requires a more detailed guidelines to be used by the surgeons.

# data[].attributes.body
Cellis will need more reinforced regulation.
- intended to replace the tissue
- contact through cellular and micro vascular infiltration
- long-term

# data[].attributes.body
Brest implant biomaterial may pose a higher risk with complication with the human body and also since it will stay in the body for a long time. The biomaterial has to be assessed for any potential risk

# data[].attributes.body
Cellis?
- specific use
- less substitute for it

# data[].attributes.body
CELLIS should be studied more thoroughly because implantation is more risky in operation and it stays longer time inside body.

# data[].attributes.body
implantable breast should have higher risk thus need to be assessed more. its also more specific case compare to the other one

# data[].attributes.body
The breast implant is long-term, so the probability of adverse side effects is greater

# data[].attributes.body
Breast implant since it probably covers larger area and it stays longer in our body (since the mesh is just for repairing)

# data[].attributes.body
Cellis breast is more likely to be highly regulated because it is implanted into the body. It is also a very specific use compared to Medeor.

# data[].attributes.body
Breast implant poses higher risk because it is implanted and stays inside the body. There is possibility for inflammation or other side effects due to immune response from our body. Therefore it should be assessed more thoroughly.

# data[].attributes.body
I guess the implantable breast as implantable devices/materials are one of the most highly regulated within the FDA (Class 3)